Bobby Portis, a key player for the Milwaukee Bucks, will miss 25 games after violating the NBA's anti-drug policy. The league handed down the suspension following Portis' positive test for Tramadol, a substance not approved for use in the NBA. This unexpected development has significant implications for both Portis and the Bucks as they navigate the remainder of the season.
The incident arose from a mix-up involving Portis and his assistant. Portis believed he was taking Toradol, a pain medication commonly used by NBA teams and players for pain and inflammation. However, the assistant, who had a valid prescription for Tramadol, mistakenly informed Portis that he was taking Toradol instead. Tramadol is typically prescribed to treat severe pain in adults but was recently added to the NBA's list of banned substances.
Portis has been an invaluable asset to the Bucks, averaging 13.7 points and 8.3 rebounds over 46 games this season. He ranks sixth in scoring and second in rebounds off the bench among NBA players. The Bucks, currently holding fifth place in the Eastern Conference with a 29-24 record, now face the challenge of continuing their playoff push without one of their premier sixth men.
Mark Bartelstein of Priority Sports expressed his disappointment over the situation:
"I am devastated for Bobby right now because he made an honest mistake and the ramifications of it are incredibly significant."
Portis is set to return on April 8 against the Minnesota Timberwolves. During his suspension, he will lose approximately $2.85 million in salary, adding financial strain to an already challenging situation. The Bucks have an open roster spot, providing them with an opportunity to make a strategic move in response to Portis' absence.
Leave a Reply